The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma

Wenhuan Huang, Zhe Zhong, Chang Luo, Yuzhong Xiao, Limin Li, Xing Zhang, Liu Yang, Kai Xiao, Yichong Ning, Li Chen,

Theranostics · 2019 · 113 citations · 74 references

DOIFull text

Open access

Concepts

Abstract

These results suggest that AP-2α reduces the stemness and TMZ resistance of glioma by inhibiting the Nanog/Sox2/CD133 axis and IL6/STAT3 signaling pathways. Therefore, AP-2α and miR-26a inhibition might represent a new target for developing new therapeutic strategies in TMZ resistance and recurrent glioma patients.

References

74